vs

Side-by-side financial comparison of Alpha Metallurgical Resources, Inc. (AMR) and Inspire Medical Systems, Inc. (INSP). Click either name above to swap in a different company.

Alpha Metallurgical Resources, Inc. is the larger business by last-quarter revenue ($519.1M vs $269.1M, roughly 1.9× Inspire Medical Systems, Inc.). Inspire Medical Systems, Inc. runs the higher net margin — 50.6% vs -3.3%, a 53.9% gap on every dollar of revenue. On growth, Inspire Medical Systems, Inc. posted the faster year-over-year revenue change (12.2% vs -15.7%). Inspire Medical Systems, Inc. produced more free cash flow last quarter ($41.8M vs $-10.0M). Over the past eight quarters, Inspire Medical Systems, Inc.'s revenue compounded faster (28.1% CAGR vs -22.4%).

Alpha Metallurgical Resources, formerly Contura Energy, is a leading coal supplier with underground and surface coal mining complexes across Northern and Central Appalachia. Contura owns large coal basins in Pennsylvania, Virginia and West Virginia which supply both metallurgical coal to produce steel and thermal coal to generate power.

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

AMR vs INSP — Head-to-Head

Bigger by revenue
AMR
AMR
1.9× larger
AMR
$519.1M
$269.1M
INSP
Growing faster (revenue YoY)
INSP
INSP
+27.9% gap
INSP
12.2%
-15.7%
AMR
Higher net margin
INSP
INSP
53.9% more per $
INSP
50.6%
-3.3%
AMR
More free cash flow
INSP
INSP
$51.8M more FCF
INSP
$41.8M
$-10.0M
AMR
Faster 2-yr revenue CAGR
INSP
INSP
Annualised
INSP
28.1%
-22.4%
AMR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMR
AMR
INSP
INSP
Revenue
$519.1M
$269.1M
Net Profit
$-17.3M
$136.1M
Gross Margin
86.6%
Operating Margin
-4.1%
17.1%
Net Margin
-3.3%
50.6%
Revenue YoY
-15.7%
12.2%
Net Profit YoY
-711.2%
286.4%
EPS (diluted)
$-1.35
$4.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMR
AMR
INSP
INSP
Q4 25
$519.1M
$269.1M
Q3 25
$525.2M
$224.5M
Q2 25
$548.7M
$217.1M
Q1 25
$529.7M
$201.3M
Q4 24
$615.4M
$239.7M
Q3 24
$669.8M
$203.2M
Q2 24
$800.1M
$195.9M
Q1 24
$861.3M
$164.0M
Net Profit
AMR
AMR
INSP
INSP
Q4 25
$-17.3M
$136.1M
Q3 25
$-5.5M
$9.9M
Q2 25
$-5.0M
$-3.6M
Q1 25
$-33.9M
$3.0M
Q4 24
$-2.1M
$35.2M
Q3 24
$3.8M
$18.5M
Q2 24
$58.9M
$9.8M
Q1 24
$127.0M
$-10.0M
Gross Margin
AMR
AMR
INSP
INSP
Q4 25
86.6%
Q3 25
85.8%
Q2 25
84.0%
Q1 25
84.7%
Q4 24
85.0%
Q3 24
84.1%
Q2 24
84.8%
Q1 24
84.9%
Operating Margin
AMR
AMR
INSP
INSP
Q4 25
-4.1%
17.1%
Q3 25
-0.5%
4.3%
Q2 25
0.5%
-1.5%
Q1 25
-7.6%
-0.7%
Q4 24
1.6%
13.3%
Q3 24
0.8%
7.0%
Q2 24
8.8%
2.6%
Q1 24
16.5%
-9.3%
Net Margin
AMR
AMR
INSP
INSP
Q4 25
-3.3%
50.6%
Q3 25
-1.1%
4.4%
Q2 25
-0.9%
-1.7%
Q1 25
-6.4%
1.5%
Q4 24
-0.3%
14.7%
Q3 24
0.6%
9.1%
Q2 24
7.4%
5.0%
Q1 24
14.7%
-6.1%
EPS (diluted)
AMR
AMR
INSP
INSP
Q4 25
$-1.35
$4.57
Q3 25
$-0.42
$0.34
Q2 25
$-0.38
$-0.12
Q1 25
$-2.60
$0.10
Q4 24
$-0.09
$1.17
Q3 24
$0.29
$0.60
Q2 24
$4.49
$0.32
Q1 24
$9.59
$-0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMR
AMR
INSP
INSP
Cash + ST InvestmentsLiquidity on hand
$415.6M
$308.3M
Total DebtLower is stronger
$9.8M
Stockholders' EquityBook value
$1.5B
$781.2M
Total Assets
$2.3B
$907.3M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMR
AMR
INSP
INSP
Q4 25
$415.6M
$308.3M
Q3 25
$457.9M
$322.6M
Q2 25
$449.0M
$300.9M
Q1 25
$448.0M
$369.2M
Q4 24
$481.6M
$445.5M
Q3 24
$484.6M
$411.0M
Q2 24
$336.1M
$439.7M
Q1 24
$269.4M
$441.4M
Total Debt
AMR
AMR
INSP
INSP
Q4 25
$9.8M
Q3 25
$2.9M
Q2 25
$3.1M
Q1 25
$2.4M
Q4 24
$2.9M
Q3 24
$3.6M
Q2 24
$5.3M
Q1 24
$6.0M
Stockholders' Equity
AMR
AMR
INSP
INSP
Q4 25
$1.5B
$781.2M
Q3 25
$1.6B
$666.5M
Q2 25
$1.6B
$677.8M
Q1 25
$1.6B
$635.7M
Q4 24
$1.6B
$689.7M
Q3 24
$1.7B
$696.6M
Q2 24
$1.6B
$638.1M
Q1 24
$1.6B
$589.0M
Total Assets
AMR
AMR
INSP
INSP
Q4 25
$2.3B
$907.3M
Q3 25
$2.3B
$807.7M
Q2 25
$2.4B
$802.2M
Q1 25
$2.4B
$730.8M
Q4 24
$2.4B
$808.4M
Q3 24
$2.5B
$796.2M
Q2 24
$2.5B
$728.4M
Q1 24
$2.5B
$685.8M
Debt / Equity
AMR
AMR
INSP
INSP
Q4 25
0.01×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMR
AMR
INSP
INSP
Operating Cash FlowLast quarter
$19.0M
$52.5M
Free Cash FlowOCF − Capex
$-10.0M
$41.8M
FCF MarginFCF / Revenue
-1.9%
15.5%
Capex IntensityCapex / Revenue
5.6%
4.0%
Cash ConversionOCF / Net Profit
0.39×
TTM Free Cash FlowTrailing 4 quarters
$17.8M
$78.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMR
AMR
INSP
INSP
Q4 25
$19.0M
$52.5M
Q3 25
$50.5M
$68.5M
Q2 25
$53.2M
$2.7M
Q1 25
$22.2M
$-6.7M
Q4 24
$56.3M
$69.2M
Q3 24
$189.5M
$52.3M
Q2 24
$138.1M
$-78.0K
Q1 24
$196.1M
$8.9M
Free Cash Flow
AMR
AMR
INSP
INSP
Q4 25
$-10.0M
$41.8M
Q3 25
$25.4M
$58.1M
Q2 25
$18.6M
$-6.3M
Q1 25
$-16.3M
$-15.1M
Q4 24
$13.6M
$62.2M
Q3 24
$158.0M
$44.3M
Q2 24
$77.0M
$-12.5M
Q1 24
$132.5M
$-2.8M
FCF Margin
AMR
AMR
INSP
INSP
Q4 25
-1.9%
15.5%
Q3 25
4.8%
25.9%
Q2 25
3.4%
-2.9%
Q1 25
-3.1%
-7.5%
Q4 24
2.2%
25.9%
Q3 24
23.6%
21.8%
Q2 24
9.6%
-6.4%
Q1 24
15.4%
-1.7%
Capex Intensity
AMR
AMR
INSP
INSP
Q4 25
5.6%
4.0%
Q3 25
4.8%
4.6%
Q2 25
6.3%
4.1%
Q1 25
7.3%
4.2%
Q4 24
6.9%
2.9%
Q3 24
4.7%
3.9%
Q2 24
7.6%
6.3%
Q1 24
7.4%
7.1%
Cash Conversion
AMR
AMR
INSP
INSP
Q4 25
0.39×
Q3 25
6.90×
Q2 25
Q1 25
-2.24×
Q4 24
1.96×
Q3 24
49.81×
2.83×
Q2 24
2.34×
-0.01×
Q1 24
1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons